Negin Mokhtari

Negin Mokhtari, Ph.D.
joined Bioluminescence Ventures as a Partner in 2023 and brings a blend of scientific expertise, operational experience, and investment skills to the firm.
Prior to joining Bioluminescence Ventures, Dr. Mokhtari was part of the investment team at Genoa Ventures, focusing on the convergence of biology and technology, and serving on the board of multiple companies.
She brings hands-on operational experience in therapeutics and diagnostics gained from her involvement in multiple startups at different developmental stages.
Her roles have spanned from spinning off startups in drug and gene delivery and drug screening as a founding team member to late-stage commercial operations in product and business development at Freenome.
Dr. Mokhtari holds a Ph.D.
in Precision Medicine and Drug Delivery from UC San Diego (Moores Cancer Center) and a B.S.
in Electrical Engineering from the University of Minnesota Twin Cities.